David
Bernardo Ordiz
Universidad de Alcalá
Alcalá de Henares, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Alcalá (5)
2021
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2020
-
Serum adipokines as non-invasive biomarkers in Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
-
Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's disease
European Journal of Gastroenterology and Hepatology, Vol. 32, Núm. 5, pp. 588-596
2019
-
Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease
Therapeutic Advances in Gastroenterology, Vol. 12